Posts Tagged ‘Sharrel Pinto’
The Toledo Family Pharmacy and the Health Outcomes and Socioeconomic Sciences (HOSS) program at The University of Toledo embarked on a collaborative partnership last year with a goal of developing the first community-based health outcomes fellowship. With changes in healthcare and the move toward outcomes-driven provision of care, there is currently a workforce deficit of health care practitioners who are trained in designing, implementing, and evaluating community-based programs that can help improve the outcomes of patients while saving costs.
After a nationwide search and a highly competitive pool of 21 applicants from around the country, the inaugural fellow was hired. Dr. Rebekah Panak is a licensed pharmacist and a graduate of the University of Oklahoma. She currently splits her time between the UTMC pharmacy and UT’s Health Outcomes and Socioeconomic Sciences division. As part of her fellowship, she will be completing a Master of Science in UT’s Health Outcomes and Socioeconomic Sciences. This program is recognized nationally and internationally for its work, and Dr. Panak will be the first fellow to graduate from this program. As part of her fellowship and thesis requirements, Dr. Panak will be working with Dr. Hussein El-Khatib (owner of the Toledo Family Pharmacy and alumnus of UT) and Dr. Sharrel Pinto (Division Head for Health Outcomes and Socioeconomic Sciences), to develop a community-based diabetes center that will provide patients in the community an opportunity to receive interprofessional care under one roof.
Poor medication adherence has dire consequences, leading to high mortality rates and lower quality of life for patients with chronic disease. Patients who have complex medication schedules may have trouble remembering to take all their medications, and they may not know what to do when they miss doses.
Dr. Sharell Pinto, director of the Pharmaceutical Care and Outcomes Research laboratory and division head for Health Outcomes and Socioeconomic Sciences, is leading the national conversation on medication adherence. As the lead investigator on the STOMPP project, she is demonstrating how community pharmacists, through medication therapy management and adherence packaging, can impact the clinical outcomes and quality of life of patients with metabolic syndrome and type 2 diabetes.
Through this study, Dr. Pinto hopes to demonstrate the effectiveness of adherence blister packaging, which simplifies adherence by grouping daily medication doses for the patient. Along with the clinical education provided by pharmacists and the continual monitoring of patients by physicians, this approach might help to improve patients’ health outcomes.
Dr. Pinto’s research was featured in Drug Topics. Read more